Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-crentre, randomized, double-blind, placebo controlled trial
The results of this study support the efficacy of naltrexone in the relapse prevention of alcoholism amongst those with low levels of clinical depression and alcohol dependence severity. No effect of acamprosate was found.
Comments